Raymond James Trust’s Takeda Pharmaceutical TAK Stock Holding History

Raymond James Trust’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,525	Closed	-$194K	–	1166
2021 Q2	$194K	Buy	11,525 +9	+0.1%	+$153	0.01%	1076
2021 Q1	$211K	Sell	11,516 -12,730	-53%	-$229K	0.01%	1009
2020 Q4	$442K	Sell	24,246 -617	-2%	-$10.8K	0.02%	598
2020 Q3	$444K	Buy	24,863 +1,568	+7%	+$28.6K	0.02%	531
2020 Q2	$417K	Sell	23,295 -365	-2%	-$6.55K	0.02%	525
2020 Q1	$359K	Buy	23,660 +3,408	+17%	+$61.8K	0.02%	491
2019 Q4	$399K	Buy	20,252 +1,006	+5%	+$19.2K	0.02%	551
2019 Q3	$331K	Buy	19,246 +5,106	+36%	+$88.3K	0.02%	614
2019 Q2	$251K	Buy	14,140 +3,213	+29%	+$58.5K	0.01%	718
2019 Q1	$222K	Buy	+10,927	New	+$220K	0.01%	734

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James Trust's TAK Position: Q3 2021 in Review

Raymond James Trust sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 11,525 shares — an estimated $194K sold.

Raymond James Trust first reported a position in TAK in Q1 2019 and held it in 10 quarters. The position peaked at $444K in Q3 2020. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

Raymond James Trust reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
Raymond James Trust sold 11,525 Takeda Pharmaceutical shares in Q3 2021, an estimated $194K.
Raymond James Trust first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 10 quarters.
Raymond James Trust's Takeda Pharmaceutical position peaked at $444K in Q3 2020.
292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Raymond James Trust's 13F filing for Q3 2021, filed 18 Oct 2021.